Sydney Lear Stoops, Phd Email & Phone Number

Wilmington, De, Us

• MSL Strategy Lead, Early Development Portfolio – Spearheaded MSL support for strategic Phase 1 site selection, engaged with Phase 1 experts, communicating insights back to clinical development team and global product strategy team to support commercialization development plan• MSL Mentorship – Mentored new MSLs, providing scientific training, strategic territory management, and guidance on core responsibilities, while offering support through training, ride-alongs, and coaching• MSL Strategy Lead, GVHD – Field based expert to support GVHD training for MSLs; Collected and communicated field insights; analyzed and identified trends from the insights to share with the pre-launch planning and the post-approval rapid response teams.• Market Access Commercial Rotation – One-year mentorship program under the direction of a Market Access colleague, completing two projects: (1) Developed launch-related Market Access promotional materials for Jakafi in cGVHD, (2) Formulated a competitive assessment of a recently approved competitor across mechanism of action (MOA) and data, branding/messaging, commercial infrastructure, pricing, and distribution.

• Developed, maintained, and expanded relationships with external experts in Midwest, Gulf Coast, and Upper South Territories to support education across 3 products with 6 indications and entire oncology clinical development portfolio• MSL Study Lead, GRAVITAS Program – Provided MSL leadership for GRAVITAS Program, including cross functional development of study SIV slide decks, participating in study team meetings, communicating study updates with field and pre-launch teams.• Planned, executed, and led multiple Institutional Meetings within my three territories – GVHD Meeting at Washington University School of Medicine, Portfolio Meeting at University of Kansas Cancer Center, Early Development Meeting at Sarah Cannon Research Institute. Attendance included leadership from Medical Affairs, Targeted, and Immuno-Oncology Development teams (including translational, clinical operations, and clinical development).• Mighty Oak Award Recipient (2018) – Recognized by the Leadership Team based on nominations from supervisor(s) and colleague(s), a Mighty Oak recipient embodies excellence in his/her position, highly motivated to achieve goals, consistently supports internal and external customers, works collaboratively, and serves as a role model.

Kansas City, Missouri Area

• Developed a biopharmaceutical analysis business stream for the Pharmaceutical Sciences Group, increasing commercial client business and capturing a portion of the $150B global market• Led commercial projects, managing technical support, timelines, business development, and client project summaries

Greater Nashville Area, Tn

• Performed scientific and financial due diligence to evaluate the novelty and market potential of start-up technologies within the areas of drug delivery systems, nutraceuticals, biotechnologies, and medical devices.• Conducted in-depth market analysis to generate new investment options within the areas of pediatric oncology and cancer diagnostics.

Lenexa, Ks

Methodology Development for Toll-like Receptor (TLR) Function AssayMentorship by Dr. Michelle Altrich

Executive Mba

Postdoctoral Fellowship

Mentor: Thomas Kodadek Development of Antibody Surrogates for the Identification of Candidate IgG Biomarkers Research focused.

Certificate, Stanford Ignite: Powering Innovation And Entrepreneurship

Focused business program examining the process of transforming innovative ideas into successful ventures through a combination.

Phd, Pharmacology

Department of Pharmacology Mentor: Craig W. Lindsley Thesis: Identification, Optimization, and Understanding the Mechanism of Action.

Ba, Microbiology, Molecular Biology

Summer Business Institute for Non-Business Majors, Farmer School of Business -Six-week business program designed to provide a competitive.